Journey Advisory Group’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Sell |
880
-1,747
| -67% | -$548K | 0.02% | 248 |
|
|
2025
Q1 | $800K | Buy |
2,627
+237
| +10% | +$72.2K | 0.07% | 164 |
|
|
2024
Q4 | $984K | Hold |
2,390
| – | – | 0.12% | 114 |
|
|
2024
Q3 | $984K | Hold |
2,390
| – | – | 0.12% | 114 |
|
|
2024
Q2 | $984K | Buy |
2,390
+44
| +2% | +$18.1K | 0.12% | 114 |
|
|
2024
Q1 | $948K | Buy |
2,346
+444
| +23% | +$179K | 0.12% | 119 |
|
|
2023
Q4 | $583K | Buy |
1,902
+82
| +5% | +$25.1K | 0.08% | 138 |
|
|
2023
Q3 | $441K | Hold |
1,820
| – | – | 0.07% | 154 |
|
|
2023
Q2 | $437K | Hold |
1,820
| – | – | 0.07% | 157 |
|
|
2023
Q1 | $342K | Sell |
1,820
-70
| -4% | -$13.2K | 0.05% | 171 |
|
|
2022
Q4 | $401K | Buy |
1,890
+265
| +16% | +$56.3K | 0.1% | 148 |
|
|
2022
Q3 | $255K | Buy |
1,625
+50
| +3% | +$7.85K | 0.07% | 202 |
|
|
2022
Q2 | $264K | Buy |
+1,575
| New | +$264K | 0.06% | 214 |
|
|
2022
Q1 | – | Sell |
-975
| Closed | -$212K | – | 220 |
|
|
2021
Q4 | $212K | Buy |
+975
| New | +$212K | 0.06% | 202 |
|